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Clinical Intestinal Transplantation 
S. Todo. A. Tzakis. K. Abu-Elmagd, J. Reyes, H. Furukawa. B. Nour. J.J. Fung, and T.E. Starzi 
WE RECENTLY reported that clinical intestinal transplantation was feasible in 17 patients because 
of improved immunosuppression with FK 506 and refined 
monitoring of graft rejection. I Described herein is the 
further follow-up of these 17 patients. and the clinical 
course of an additional 13 cases of intestinal transplanta-
tion performed thereafter. 
PATIENTS AND METHODS 
Case Material 
During a two-and-a-half-year period. from May 1990 through 
November 1992.30 patients underwent intestinal transplantation 
at our center. Fifteen patients were children and IS were adults. 
Age. indication for transplantation. type of transplantation. and 
outcome are listed in Tables I and 2. Preoperatively. all of the 
patients were maintained by total parenteral nutrition (TPN) from 
I to 132 months and expenenced various TPN-related complica-
tions such as sepsis. mineral deficiency. cholelithiasis. cholesta-
sis. and portal hypertension. 
All of the grafts were obtained from cadaveric donors of similar 
size and the same blood type as the recipient. Grafts were 
preserved with University of Wisconsin solution for a mean 
duration of 7.7 hours (ranging from 2.8 to 11.1 hours). No 
immunomodulation. either by administration of anti-lymphocyte 
globulin or irradiation. of the donor or graft was carried out. 
Three different methods of intestinal transplantation were em-
ployed: isolated small bowel graft (S8). combined small bowel 
and liver graft (SBIL). or a composite of abdominal organs 
(multivisceral graft. MV). The type of transplantation procedure 
used depended on the cause of intestinal failure and the severity of 
extra-enteric organ failure. especially the liver. An isolated small 
bowel graft consIsted of the entire intestine. except for short 
segments proximal to the ligament of Treitz and distal to the 
ileocecal valve. Nine patients (3 children and 6 adults) who had 
intestinal failure but nonnal liver function received an isolated 
small bowel graft. Seventeen patients (II children and 6 adults) 
who had intestinal and liver failure received a combined small 
bowel and liver graft. The liver and small bowel were transplanted 
simultaneously and in continuity with the portal vein and their 
central arteries. Abdominal multivisceral transplantation was per-
fonned in 3 adult patients who had thrombotic abnonnalities at the 
celiac axis (CA) and superior mesenteric artery (SMA). and in one 
child who had an extensive motility disorder throughout her entire 
gastrointestinal tract (from the stomach to the rectum). The 
multivisceral grafts included the stomach. liver. pancreas. and 
small bowel. and on one occasion the colon as well. Surgical 
procedures of graft procurement and transplantation were de-
scribed before. 2-4 
Postoperative immunosuppressive therapy of intestinal trans-
plant recipients was similar to the therapy for liver transplant 
recipients. Briefly. intravenous FK 506 (0.1 mglkg per day) was 
started immediately after the graft was revascularized. and was 
continued until oral dosing of FK 506 (0.3 mglkg per day) was 
feasible. Oral FK 506 was begun when patients were able to 
tolerate enteral feeding. A bolus injection of steroids was given 
intraoperatively and followed by a tapering of steroids thereafter. 
Prostaglandin EI (0.6 to 0.8 ~g per hour) was given for 5 to 25 
days postoperatively. and Imuran was given as a immunosuppres-
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Table 1. Pediatric SmIIll Bowel Tl1lnapiantation 
Transpianted Grall 
Patient Age Sex C- 01 Sholt-Gut Syndrome Organs Survival' TPN Status 
1 3.2 F NecrotIZIng enterocolitis Small bowel-liver >30 Free 
2 4.3 M Gastroschisis Small boweI-liver >26 Free 
3 2.8 M Intestinal atresia Small bowel-liver 13 Oied.LPD 
4 0.6 F Intestinal atresia Small bowel-liver Died. GVHD and SepsIS 
5 1.1 F Volvulus Small bowel-liver >18 Free 
6 1.7 F Volvulus Small bowel-liver >18 Free 
7 2.5 F MiaovIllus inclusion disease Small bowel >15 Free 
8 1.3 M Intestinal atresia Small bowel >13 Free 
9 10 F Pseudo-obs1ructi Small bowel >11 Free 
10 1.5 M NacrotiZing enterocolitis Small bowel-liver 2 Died. sepsIS 
11 4.2 F Gastroschisis Small bowel-liver >8 Free 
12 1.4 M G88Irosct1isis Small bowel-liver 1 Died. sepsis 
13 0.8 M MiaovIlius Inclusion disease Small boweI-liver >6 Free 
14 0.5 M Gastroschisis Small bowel-liver >6 Free 
15 4.5 F Pseudo-obstrUction Multivisceral >3 Free 
'Sul'VlvaI In monIhs as of JanuIIy 1993. 
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Table 2. Adult 81N111 Bowel qIK~n 
Patient 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Age 
31 
27 
21 
32 
50 
34 
38 
22 
25 
29 
24 
20 
31 
19 
44 
Sex 
M 
F 
M 
M 
F 
F 
M 
F 
. M 
F 
M 
F 
F 
M 
F 
'SUrvival in months as of JanU8IY 1993. 
cause of Short-Gut 
Syndrome 
Gunshot wound 
SMA thrombosis 
Traflic accident 
CA & SMA thrombosis 
Crohn's disease 
Desmoid tumor 
Crohn's disease 
Crohn's disease 
Crohn's disease 
Desmoid tumor 
CA & SMA thrombosis 
Tralfic accident 
CA & SMA thrombosis 
Tralfic accident 
SMA thrombosis 
sive supplement to patients for whom sufficient doses of FK 506 
were hard to maintain. 
Monitoring and treatment of intestinal graft rejection was done 
as previously described, in which careful evaluation of clinical 
course, endoscopic finding. and histopathologic study of endo-
scope'guide biopsies were essential. I Enteral feeding was usually 
started from 1 to 2 weeks (average of 17 days) posttransplant and 
augmented gradually as TPN was decreased. To prevent bacterial 
translocation, selective decontamination of the gastrointestinal 
tract was continued for 4 to 8 weeks posttransplant. 
RESULTS 
Isolated Small Bowel Transplantation 
Of the 9 SB recipients, 8 (88.8%) are alive from 8 to 15 
months. One patient died of overwhelming sepsis 71 days 
after retransplantation. This patient was retransplanted 
after 22 months for drug·noncompliant rejection. Another 
graft had to be removed at 8 months because of acute 
rejection: immunosuppression was stopped due to demy· 
elination of the white matter of the brain. The patient was 
restarted on TPN, Currently. 7 of the 10 grafts (9 primary 
grafts and I retransplanted graft) are functioning, All 7 of 
the patients with functioning grafts are maintaining their 
nutritional requirements without TPN support. 
Combined Liver and Small Bowel Transplantation 
Thirteen of the 17 SBIL recipients (76%) are alive from 5 to 
30 months posttransplant. Four pediatric patients died: 3 
due to sepsis and I due to postoperative Iymphoprolifera· 
tive disease. Technical complications (intestinal anasto-
motic leakage, biliary anastomotic leakage, or hepatic 
artery thrombosis) were the cause of the lethal septic 
complications in the 3 pediatric patients. In addition to the 
technical complication, 1 patient that died 23 days post· 
transplant was also found to have graft.versus·host disease 
(GVHD). Immunohistochemical examination of skin biop-
Transplanted Grall 
Organs Survival' TPN Status 
Small bowel 22 Graft removed, retransplant 
Small bowel 2 Died, sepsis 
Small boweI-liver >30 Free 
Small bowel-liver >17 Partial 
MultiVisceral >15 Free 
Small bowel >13 Free 
Small bowel 8 Graft removed, encephalitis 
Small bowel >11 Free 
Small bowel >11 Free 
Small bowel-liver >10 Free 
Small boweI-liver >8 Free 
MultiVisceral >8 Free 
Small bowel >8 Free 
MultiVisceral >6 Free 
Small boweI-liver >5 Free 
Small bowel-liver >5 Free 
sies revealed GVHD at 22 days, but not at 19 days. All of 
the 13 surviving recipients. except for one. are completely 
free from TPN. 
Abdominal Multivisceral Transplantation 
Abdominal multi visceral transplantation was performed in 
4 patients (1 pediatric patient and 3 adults). All 4 of the 
patients are alive with functioning grafts from 3 to 15 
months, 
COMMENTS 
Intestinal transplantation is a theoretical choice of treat· 
ment for patients who have irreversible intestinal failure. 
However. except for a few isolated cases of success. 
rejection. technical problems. sepsis. and poor graft pres· 
ervation have prevented successful results in the more 
than two dozen attempts at small bowel transplantation 
under conventional immunosuppression , 5-7 The major ob-
stacle in the past was the inability to control and to monitor 
graft rejection, The intestine is thought to induce graft 
rejection more vigorously than other organs. because it has 
abundant lymphoreticular cells in the Peyer's patches. 
lamina propria. and mesenteric lymph nodes. Although 
rejection of the liver and kidney can be estimated by the 
elevation of bilirubin and creatinine. respectively. there is 
no biochemical marker of intestinal damage. In our expe· 
rience with 30 small bowel transplant recipients. a new and 
potent immunosuppressant. FK 506. was used for post· 
transplant prevention: control of rejection and histopatho· 
logic analysis of endoscope·guided biopsies was used for 
monitoring of graft rejection. As shown with the transplan· 
tation of the liver. kidney. heart. or lung.8 FK 506 is also 
able to exhibit its potent anti· rejection effect on the intes· 
tine. Contrary to prior assumptions on the unreliability of 
pathologic diagnosis of small bowel rejection. endoscope· 
fI 
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guided mucosal biopsies of the small bowel graft and 
clinical impression offered sufficient infonnation to diag-
nose rejection. 
Although the indications need to be carefully appraised 
according to individual cases, three different types of 
intestinal transplantation can be perfonned. Isolated small 
bowel transplantation is indicated for patients who have 
problems only with their intestine. Combined liver and 
small bowel transplantation is indicated for patients who 
have both liver and intestinal failure. Multivisceral trans-
plantation is indicated for patients who have extensive 
thrombotic disorders involving both the celiac axis and 
superior mesenteric artery or possibly the splanchnic sys-
tem. Multivisceral transplantation may also be indicated 
for patients who have a severe motility disorder that 
involves the entire gastrointestinal tract. 
Although a much longer follow-up and a refinement of 
postoperative management are required. our experience 
2197 
with these 30 recipients suggests that intestinal transplan-
tation is becoming a practical reality. 
REFERENCES 
I. Todo S. Tzakis AG. Abu-Elmagd K. et a1: Ann Surg 216:223. 
1992 
2. Starzl TE. Todo S. Tzakis A. et a1: Surg Gynecol Obstet 
172:335. 1991 
3. Casavilla A. Selby R. Abu-Elmagd K. et a1: Ann SW'I 
216:85, 1992 
4. Tzakis AG. Todo S. Reyes J. et a1: Surg Gynecol Obstet 
176:297. 1993 
5. Grant D. Wall W. Mimeault R. et a1: Lancet 335:181. 1990 
6. Deitz E. Schroeder P. Gebhardt H. et a1: Clin TranspI3:89. 
1989 
7. Goulet O. Revillon Y. Brousse N. et a1: Transplantation 
53:940. 1992 
8. Starzl TE. FungJJ. Todo S. eta!: Transplant Proc 23(6) 1991 
